RepliCel Life Sciences Inc (RP)

0.3150
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.3150/0.3300
  • Day's Range:
    0.3100 - 0.3300
  • Type:Equity
  • Market:Canada
  • ISIN:CA76027P4006
  • CUSIP:76027P400

RP Overview

Prev. Close
0.31
Day's Range
0.31-0.33
Revenue
360K
Open
0.32
52 wk Range
0.14-0.58
EPS
-0.11
Volume
0
Market Cap
11.65M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
11,185
P/E Ratio
-
Beta
0.83
1-Year Change
142.31%
Shares Outstanding
37,051,213
Next Earnings Date
Oct. 21, 2021
What is your sentiment on RepliCel Life Sciences Inc?
or
Vote to see community's results!

RepliCel Life Sciences Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsSellSellSellStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellSell

RepliCel Life Sciences Inc Company Profile

RepliCel Life Sciences Inc Company Profile

Sector
Services
Employees
1
Market
Canada

Replicel Life Sciences Inc is a Canada-based regenerative medicine company. It develops autologous cell therapies that treat functional cellular deficits. Its product pipeline includes RCT-01-Tendon Repair, RCS-01-Skin Rejuvenation, RCH-01-Hair Regeneration and RCI-02-Dermal Injector. RCT-01 is an autologous cell-based treatment utilizing non-bulbar dermal sheath cells isolated from the hair follicle sheath to treat chronic tendinosis caused by acute and chronic tensile overuse. RCH-01 also utilizes dermal sheath cup cells isolated from the hair follicle to treat androgenetic alopecia. RCI-02 is a dermal injector designed to control intradermal (dermis), subcutaneous (fat) or intramuscular injections. It is designed to support the injection of RCH-01 and RCS-01 cell therapy products. The injector has applications for dermatological procedures requiring injections of specific volumes of material at specific depths, including cellular products, fillers and collagen injections.

Read More
  • Bonne augmentation
    0
    • Is this ever going to be profitable?
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.